Table 7

Some newer strategies for an HIV vaccine

Replicating vectors, e.g. Adenoviruses 4 and 7, CMV, Sendai, VSV, alphavirus-VSV


DNA plasmids with electroporation


Non-parenteral routes of administration: intranasal, rectal, sublingual


DNA/NYVAC prime boost regimen


Gene-driven HIV antibody


Anti-phospholipid antibodies


Live, attenuated HIV, e.g. Δnef, Δnef/vpr, ΔGY


(Canarypox/gp prime-boost 120 trial still ongoing in Thailand)


Plotkin Journal of the International AIDS Society 2009 12:2   doi:10.1186/1758-2652-12-2

Open Data